Coronavirus live news: Trump says he 'perhaps' misled Americans as global deaths pass 900,000

Trials of Oxford University’s potential coronavirus vaccine could resume within days after being paused for an urgent investigation into possible adverse side-effects.

It is understood that Astrazeneca, the British drugmaker working with Oxford, halted new enrolment on trials after a British volunteer showed symptoms of transverse myelitis (TM), a rare inflammatory condition that affects the spinal cord.

Stat, the health industry website which first reported the hiatus, said that a woman was suspected to have TM but the diagnosis was not confirmed, and she was on course to be discharged from hospital as early as last night.


READ  Survival of the cooperative - Science & Tech - WORLD News Group


Please enter your comment!
Please enter your name here